Anisha Wharton serves as Head of Regulatory Affairs at as Senior Vice President of Marketing at AVEO Oncology, an LG Chem company, and brings more than 16 years of global regulatory leadership to support the development, registration and life-cycle management of biologics and pharmaceutical products. Prior to joining AVEO in 2021, Ms. Wharton served as
Deb Wall serves as the Director of Human Resources at as Senior Vice President of Marketing at AVEO Oncology, an LG Chem company, and brings more than a decade of experience leading the human resource functions of both private and public companies. Ms. Wall brings deep human resources and culture-building experience to AVEO in which
Dr. Adebunmi (Bunmi) Urakpo serves as Vice President of Pharmacovigilance for AVEO Oncology, an LG Chem Company, bringing over 20 years of experience in drug safety and pharmacovigilance, clinical research, and public health. Dr. Urakpo most recently served as a Pharmacovigilance and Drug Safety Consultant at NADDBio LLC (“NADDBio”), a clinical-stage R&D consultancy firm. Prior
Noelia Rycerz brings more than 19 years of global drug development experience to her role as Vice President of Clinical Operations at AVEO Oncology, an LG Chem company. Ms. Rycerz has held roles of increasing seniority in Clinical Operations and Program Management at Amgen Inc. (“Amgen”), Pfizer Inc. (“Pfizer”), and Odonate Therapeutics, Inc. She has
Kevin Peacock currently serves as as Senior Vice President of Marketing at AVEO Oncology, an LG Chem company. Prior to joining AVEO, he served as both the Vice President, New Product Planning and Business Development at Lycera where he was leading the early commercialization process for Lycera’s novel immune-oncology compounds and in 2015 completed an
Greg Oehrtman brings over 20 years of Drug Development experience to his role returning to AVEO Oncology, an LG Chem company, after 8 years. Dr. Oehrtman has held roles of increasing seniority in Drug Development and Manufacturing at Quintiles/Catalent, Amylin, Stealth Biotherapeutics, and Dicerna. He has led both drug substance and product development and manufacturing from
Jason Noto brings over 20 years of broad commercial leadership experience to his role as Senior Vice President of Market Access at AVEO Oncology, an LG Chem company. Prior to joining AVEO, Jason served as Vice President at 1798 Consultants, a strategic market access consultancy specializing in integrated channel strategy, patient support services (HUB), payer
Dr. Claudia Lebedinsky serves as Senior Vice President, Head of Clinical Development of AVEO Oncology, an LG Chem company, bringing more than 20 years of experience in oncology and clinical development to the organization. Dr. Lebedinsky most recently served as Vice President, Head of Clinical Development at Sumitomo Pharma Oncology (Sumitomo), where she led the
Peter Kim serves as Director of Financial Planning & Analyisis of AVEO Oncology, an LG Chem company. With a financial career spanning over 27 years, Mr. Kim has held various financial roles in the pharmaceutical and banking industries. Prior to joining AVEO’s management team, he served as Associate Director, Business Planning & Analysis (Commercial) Oncology, Ophthalmology
Dr. Bo Jin serves as Vice President of Biostatistics and Data Management at AVEO Oncology, an LG Chem company, bringing over 20 years of industry experience in biostatistics, data management, programming, and data sciences. Dr. Jin most recently served as Vice President of Biostatistics and Programming at SinoCellTech Group Limited (SinoCell), where he was responsible